Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation

Luciano Baronciani

Flora Peyvandi: Characterizing Acquired VWD Through a Large Patient Cohort
Jun 21, 2026, 05:32 | Science
Flora Peyvandi: Characterizing Acquired VWD Through a Large Patient Cohort
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of…
Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
Jan 9, 2026, 07:19 | Science
Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital,…
Deep Molecular Modeling for Type 2A VWD from Omid Seidizadeh
Dec 7, 2025, 15:20 | Science
Deep Molecular Modeling for Type 2A VWD from Omid Seidizadeh
RPTH Journal shared on LinkedIn: ''Fascinating new study on Type 2A Von Willebrand Disease from…
von Willebrand Disease - Nature Reviews Disease Primers
Dec 6, 2025, 06:23 | Science
von Willebrand Disease - Nature Reviews Disease Primers
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared an…
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2 VWD
Nov 12, 2025, 04:54 | Science
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2 VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared on…
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD
Oct 23, 2025, 06:48 | Science
Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared on…
Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
Sep 12, 2025, 03:38 | Science
Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, has shared a…
Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
Sep 10, 2025, 08:20 | Science
Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
Omid Seidizadeh: Effect of Some Polymorphic Variants on the Platelet-Dependent VWF Activity Assays
Aug 19, 2025, 17:36 | Science
Omid Seidizadeh: Effect of Some Polymorphic Variants on the Platelet-Dependent VWF Activity Assays
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared an…
Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
Aug 14, 2025, 17:54 | Science
Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared an…
All: 10 Posts: 1 - 100
NewsFeed